StockWatch
·
Pharmaceuticals
Corporate Governance13 Apr 2026, 04:51 pm

Advik Labs reports NIL investor complaints for Q4 FY26

AI Summary

Advik Laboratories Ltd has submitted its statement of investor complaints for the quarter ended March 31, 2026, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company reported zero investor complaints pending at the beginning of the quarter, zero complaints received during the quarter, zero complaints disposed of, and zero complaints remaining unresolved at the end of the quarter.

Key Highlights

  • Advik Labs reported zero investor complaints for Q4 FY26.
  • No complaints were pending at the quarter's beginning.
  • Zero new complaints were received during the quarter.
  • No complaints remained unresolved at quarter-end.